<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-07-08T08:44:08Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/9C1ADF45-2A3C-4970-A382-A8AC56962E9B" ns1:id="9C1ADF45-2A3C-4970-A382-A8AC56962E9B"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/34D3134F-486B-4799-90C2-516E92111741" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/F938CAB1-F43D-45E2-96F3-822753641D76" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/F938CAB1-F43D-45E2-96F3-822753641D76" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2024-12-31T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/90DEFF9A-289D-4CF8-B675-BD3FC8C75C3F" ns1:rel="FUND" ns1:start="2023-06-30T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">10067259</ns2:identifier></ns2:identifiers><ns2:title>Developing the world's first baby-milk free from carcinogenic and genotoxic tropical oils</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Collaborative R&amp;D</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Kendal Nutricare (KNC), a rapid-growth and Queens Award winning British family business, is seeking to disrupt the $40-billion per-year global infant-formula market by developing a world-first innovation in baby milk that will be safer, nutritionally-superior, more naturally and sustainably-made and scientifically closer to the gold-standard of breastmilk.

The prototype recipe (code-name 'Kendamil-Bio'), will be represent a fundamentally innovative formulation, not before attempted in the industry's 150-year history, to replace known ingredients containing harmful toxins with novel, natural ingredients that enhance infant-safety, nutritional-quality, proximity to breastmilk and prouct sustainability. This project will leverage KNC teams' 500+ years' cumulative expertise in infant nutrition innovation to provide infants the most nutritionally-complete, environmentally-sustainable baby-milk in the world, one designed to be uniquely closer to human-milk by incorporating several breastmilk components linked to cognitive development and strengthened immunity in children, at levels never before reached in infant formulations.

Development of the Kendamil-Bio prototype, a world-first product made here in the UK, will comprise an 18 month project involving 24 KNC team members including R&amp;amp;D technicians, food scientists, quality assurance professionals, production engineers and senior management, carried out at KNC's world-class, BRC AA-grade, FDA-registered production facilities in Kendal, gateway to the English Lake District, a UNESCO World Heritage Site.

Successful development of a novel, safer, nutritionally-superior and more environmentally-sustainable baby-milk is estimated to deliver material export revenue, re-investment in British agriculture and local skilled employment opportunities, while showcasing to the global formula industry a more effective, secure, ethical and sustainable standard of manufacturing that can be achieved, led by our world-class capabilities here in the UK.</ns2:abstractText></ns2:project>